The leaves soak up the early fall sun and we wrap up another busy news week. We’re reviewing big artificial intelligence announcements from Microsoft and its chief competitors; more funding for Remitly; a conversational competition from Amazon; a milestone launch for... Read more »
[Updated 9/30/16, 3:34 pm. See below.] September was a busy month for tech startup funding and acquisition news in the Boston area. Here are a few of the latest deals that you might’ve missed:
—Building Engines, a... Read more »
The presidential race captivated millions of TV viewers this week as the first debate took place in Hofstra. But biotech watchers had other races on their mind. Who will be first to market with a new type of cancer treatment known... Read more »
The first experimental cell-based cancer immunotherapy, known as CAR-T, could soon be submitted to the FDA for approval. But CAR-T therapies have limitations. One of many companies looking to improve them is tiny Boston startup SQZ Biotech, and it just pulled... Read more »
Arrowhead Pharmaceuticals and Amgen will together work to develop and commercialize two drugs designed to treat cardiovascular disease, the companies said Thursday.
Under the terms of the agreements, Amgen will pay Arrowhead a combined $56.5 million—$35 million in cash, and the... Read more »
Startup creation firm Allied Minds announced a partnership Thursday with GE’s venture arm to jointly invest in promising technologies.
The deal speaks to broader trends in how companies get formed and funded beyond traditional means like venture capital and the public... Read more »
With public interest in artificial intelligence technologies on the rise, five of the world’s largest corporations—vying against each other in so many spheres—are banding together to support research on the ethical and societal issues raised by machines with increasingly human-like capabilities.... Read more »
San Antonio — For a researcher trying to turn their science into a business, sometimes the big issues—such as perfecting an intricate scientific process like gene editing—feels like a less daunting task than what might seem to be smaller stuff, like... Read more »
Gener8tor, a startup accelerator whose programs have taken place exclusively in Wisconsin up to this point, took a key step forward in its expansion into Minnesota this week.
The University of Minnesota’s technology transfer arm, known as the Office for... Read more »
[Corrected, 9/29/16, 4:24 p.m. See below.] Cancer immunotherapy has captured the medical world’s attention, knocking out a few types of cancer in a small portion of the most desperate patients. But it has bumped into many limitations.
Researcher Wendell... Read more »
Houston—Aging 2.0 now has a perch in the home of one of the world’s largest medical centers.
The San Francisco-based organization, focused on supporting innovation tailored to the needs of older adults, kicks off its Houston chapter today with... Read more »
To date, the studies Genocea Biosciences has run have not made clear how much better its experimental genital herpes vaccine is than a placebo at treating patients with the infection. Genocea is touting new results today that bolster its case for... Read more »
If Ginkgo Bioworks has its way, robots and software will someday handle most of the genetic engineering work currently performed by scientists sitting at lab benches.
Ginkgo is contributing to that shift. Today the synthetic biology company announced an expansion of... Read more »